GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Total Tax Payable

Artrya (ASX:AYA) Total Tax Payable : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Artrya Total Tax Payable?

Artrya's Total Tax Payable for the quarter that ended in Dec. 2024 was A$0.00 Mil.


Artrya Total Tax Payable Historical Data

The historical data trend for Artrya's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya Total Tax Payable Chart

Artrya Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Total Tax Payable
- - - -

Artrya Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Tax Payable Get a 7-Day Free Trial - - - - -

Artrya Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.


Artrya Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Artrya's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Artrya Business Description

Traded in Other Exchanges
N/A
Address
1257 Hay Street, West Perth, Perth, WA, AUS, 6005
Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines